Antibodies face the challenge against human respiratory syncytial virus

Rory D. de Vries; Rik L. de Swart

doi:10.1016/j.chom.2022.12.010

Antibodies face the challenge against human respiratory syncytial virus

Rory D. de Vries, Rik L. de Swart^*

^*Corresponding author for this work

Virology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

Abstract

In the December 22 issue of Cell, Bartsch et al. describe functional profiling of the antibody response to respiratory syncytial virus in human adults vaccinated with an experimental adenovirus-based prefusion-stabilized HRSV-F vaccine and subsequently intranasally challenged with HRSV. The authors identified various antibody effector functions as humoral correlates of protection.

Original language	English
Pages (from-to)	135-136
Number of pages	2
Journal	Cell Host and Microbe
Volume	31
Issue number	1
DOIs	https://doi.org/10.1016/j.chom.2022.12.010
Publication status	Published - 11 Jan 2023

Bibliographical note

Publisher Copyright:
© 2022 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.chom.2022.12.010

Cite this

@article{387940567a6f43a19aefc6e8ee5ec952,

title = "Antibodies face the challenge against human respiratory syncytial virus",

abstract = "In the December 22 issue of Cell, Bartsch et al. describe functional profiling of the antibody response to respiratory syncytial virus in human adults vaccinated with an experimental adenovirus-based prefusion-stabilized HRSV-F vaccine and subsequently intranasally challenged with HRSV. The authors identified various antibody effector functions as humoral correlates of protection.",

author = "{de Vries}, {Rory D.} and {de Swart}, {Rik L.}",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2023",

month = jan,

day = "11",

doi = "10.1016/j.chom.2022.12.010",

language = "English",

volume = "31",

pages = "135--136",

journal = "Cell Host and Microbe",

issn = "1931-3128",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Antibodies face the challenge against human respiratory syncytial virus

AU - de Vries, Rory D.

AU - de Swart, Rik L.

PY - 2023/1/11

Y1 - 2023/1/11

N2 - In the December 22 issue of Cell, Bartsch et al. describe functional profiling of the antibody response to respiratory syncytial virus in human adults vaccinated with an experimental adenovirus-based prefusion-stabilized HRSV-F vaccine and subsequently intranasally challenged with HRSV. The authors identified various antibody effector functions as humoral correlates of protection.

AB - In the December 22 issue of Cell, Bartsch et al. describe functional profiling of the antibody response to respiratory syncytial virus in human adults vaccinated with an experimental adenovirus-based prefusion-stabilized HRSV-F vaccine and subsequently intranasally challenged with HRSV. The authors identified various antibody effector functions as humoral correlates of protection.

UR - http://www.scopus.com/inward/record.url?scp=85144781125&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2022.12.010

DO - 10.1016/j.chom.2022.12.010

M3 - Comment/Letter to the editor

AN - SCOPUS:85144781125

SN - 1931-3128

VL - 31

SP - 135

EP - 136

JO - Cell Host and Microbe

JF - Cell Host and Microbe

IS - 1

ER -

Antibodies face the challenge against human respiratory syncytial virus

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this